Assessment of Depression and Drug Adherence among Type II Diabetes Patients Residing in Urban Field Practice area of Sri Siddhartha Medical College Tumkur

Savitha Rani B.B, Vinay K S, Krishna Iyengar


Background: India has the largest number of diabetic populations in the world, Depression is common among people with diabetes, and it is associated with worse diabetes outcomes, non-adherence to medication is potentially one of the most serious problems facing diabetes care delivery. The objective of the study was to assess depression among type II diabetes patients and to assess adherence to therapy among type II diabetes patients.

Methodology: This cross‑sectional community‑based study was conducted in the urban field practice area of the Department of Community Medicine, SSMC, Tumkur. A total of 200 type II diabetes patients were selected by simple random sampling method from the database of Urban Health Training Centre and were traced to their homes for data collection. Data analysis was done using descriptive statistics like proportion and inferential statistics like Chi-square test. P-value less than 0.05 was taken as statistically significant.

Results: Out of 200 diabetic subjects, 80 (40%) belongs to age group 50-59 years, females were 132 (66%), Most of them 66 (33%) were having diabetes for duration of 6-10 years, most of them 176 (88%) were on oral hypoglycaemic agents. Out of 200 study subjects 93 (46.5%) had low adherence, 106 (53%) had medium adherence. 34 (17%) study subjects had depression using PHQ9 questionnaire. When we studied association of depression with other factors, it showed statistically significant results with gender (P=0.003), glycaemic status (P=0.01) and adherence to drugs (P=0.03). Association of drug adherence with depression showed statistically significant results (P=0.01).

Conclusion: Health care professionals can play a major role in improving adherence to therapy in patients of DM which prevents complication and improve Quality of life.


Diabetes Mellitus, Drug adherence, Depression

Full Text:



King H, Auburt RE, Herman WH. Global burden of

diabetes: 1995-2025: prevalence, numerical estimates,

and projections. Diabetes Care 1998; 21: 1414-31.

de Groot M, Anderson R, Freedland KE et al. Association

of depression and diabetes complications: a metaanalysis.

Psychosomatic Med 2001; 63: 619-30.

Katon J, Simon G, Russo J et al. Quality of depression

care in a population-based sample of patients with

diabetes and major depression. Med Care 2004; 42:


Katon WJ, Rutter C, Simon G et al. The association of

comorbid depression with mortality in patients with

type 2 diabetes. Diabetes Care 2005; 28: 2668-72.

Melikian C, White TJ, Vanderplas A et al. Adherence to

oral diabetic therapy in a managed care organization.

Clinical Therapy 2002; 24(3): 460-7.

Hernandez-Ronquillo L, Tellez-Zenteno JE, Garduno-

Espinosa J et al. Factors associated with therapy

noncompliance in type 2 diabetes patients. Salud

Publica Mex 2003; 45(3): 191-7.

Kendrick T, Dowrick C, McBride A et al. Management

of depression in UK general practice in relation to

scores on depression severity questionnaires: analysis

of medical record data. Br Med J 2009; 338: 750.

Ali S, Stone MA, Peters JL et al. The prevalence of

co-morbid depression in adults with type 2 diabetes:

a systematic review and meta-analysis. Diabet Med2006; 23: 1165-73.

Jorga J. Factors mediating the depression in the adult

obese outpatients. Srp Arh Celok Lek 2007; 135: 61-6.

Sacco WP, Wells KJ, Friedman A et al. Adherence,

body mass index, and depression in adults with type

diabetes: the mediational role of diabetes symptoms

and self-efficacy. Health Psychol 2007; 26: 693-700.

Bruce DG, Davis WA, Starkstein SE et al. prospective

study of depression and mortality in patients with type

diabetes: the fremantle diabetes study. Diabetologia

; 48(12): 2532-9.

Engum A. The role of depression and anxiety in onset

of diabetes in a large population-based study. Journal

of Psychosomatic Research 2007; 62(1): 31-8.

Mason BJ, Matsuyama JR, Jue SG. Assessment

of Sulfonylurea adherence and metabolic control.

Diabetes Educ 1995; 21(1): 52-7.

Paes AH, Bakker A, Soe-Angie CJ. Impact of dosage

frequency on patient compliance. Diabetes Care 1997;

(10): 1512-7.

Peyrot M, Rubin RR, Lauritzen T et al. Psychosocial

problems and barriers to improved diabetes

management: results of the cross-national diabetes

attitudes, Wishes and Needs (DAWN) Study. Diabet

Med 2005; 22(10): 1379-85.


  • There are currently no refbacks.

Comments on this article

View all comments

Copyright (c) 2018 International Journal of Preventive, Curative & Community Medicine (ISSN: 2454-325X)

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.